Paradigm Capital Management Inc. NY Decreases Stock Holdings in Nature's Sunshine Products, Inc. (NASDAQ:NATR)

Paradigm Capital Management Inc. NY lowered its position in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) by 3.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 819,200 shares of the company's stock after selling 32,400 shares during the period. Paradigm Capital Management Inc. NY owned 4.43% of Nature's Sunshine Products worth $12,009,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Russell Investments Group Ltd. acquired a new position in shares of Nature's Sunshine Products during the 4th quarter worth about $41,000. Amundi purchased a new position in Nature's Sunshine Products in the fourth quarter valued at approximately $63,000. Deutsche Bank AG acquired a new stake in Nature's Sunshine Products during the fourth quarter worth approximately $103,000. Wells Fargo & Company MN raised its holdings in Nature's Sunshine Products by 28.8% during the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company's stock worth $106,000 after purchasing an additional 1,611 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its position in shares of Nature's Sunshine Products by 346.9% during the 4th quarter. BNP Paribas Financial Markets now owns 11,719 shares of the company's stock worth $172,000 after buying an additional 9,097 shares during the last quarter. Hedge funds and other institutional investors own 79.40% of the company's stock.

Nature's Sunshine Products Price Performance

Shares of NASDAQ:NATR opened at $14.88 on Tuesday. Nature's Sunshine Products, Inc. has a 1-year low of $10.81 and a 1-year high of $18.06. The stock has a market cap of $273.06 million, a P/E ratio of 16.91 and a beta of 1.10. The firm has a fifty day moving average price of $12.60 and a 200 day moving average price of $14.12.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.25 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.09. Nature's Sunshine Products had a net margin of 3.81% and a return on equity of 11.08%. The business had revenue of $113.25 million during the quarter, compared to analysts' expectations of $109.39 million.

Wall Street Analyst Weigh In

Separately, DA Davidson started coverage on shares of Nature's Sunshine Products in a research report on Wednesday, May 7th. They issued a "buy" rating and a $19.00 target price on the stock.

Nature's Sunshine Products Company Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.